The management of erectile dysfunction in men with diabetes mellitus unresponsive to phosphodiesterase type 5 inhibitors
AA Cayetano‐Alcaraz, T Tharakan, R Chen… - …, 2023 - Wiley Online Library
Introduction Erectile dysfunction is associated with diabetes mellitus with an estimated
prevalence of 52.5% in the diabetic population. The first‐line therapy for erectile dysfunction …
prevalence of 52.5% in the diabetic population. The first‐line therapy for erectile dysfunction …
The role of tissue biomechanics in the implantation and performance of inflatable penile prostheses: current state of the art and future perspective
S Bose, B Fereidoonnezhad… - Sexual medicine …, 2023 - academic.oup.com
Introduction Erectile dysfunction (ED) affects to some degree approximately 52% of the male
population aged 40–70 years. Many men do not respond to, or are precluded from using …
population aged 40–70 years. Many men do not respond to, or are precluded from using …
Polydeoxyribonucleotide and Shock Wave Therapy Sequence Efficacy in Regenerating Immobilized Rabbit Calf Muscles
YJ Lee, YS Moon, DR Kwon, SC Cho… - International Journal of …, 2023 - mdpi.com
This study primarily aimed to investigate the combined effects of polydeoxyribonucleotide
(PDRN) and extracorporeal shock wave therapy (ESWT) sequences on the regenerative …
(PDRN) and extracorporeal shock wave therapy (ESWT) sequences on the regenerative …
The efficacy of Li-ESWT combined with VED in diabetic ED patients unresponsive to PDE5is: a single-center, randomized clinical trial
R Tao, J Chen, D Wang, Y Li, J Xiang… - Frontiers in …, 2022 - frontiersin.org
Introduction Phosphodiesterase type 5-inhibitors (PDE5is) are the first-line treatment for
patients with diabetes mellitus-induced erectile dysfunction (DMED), however, some …
patients with diabetes mellitus-induced erectile dysfunction (DMED), however, some …
[HTML][HTML] Low-intensity extracorporeal shockwave therapy for erectile dysfunction: an overview of systematic reviews
F Yuan, Y Wang, Z Ma, M Jing, Y You, X Yu… - Translational …, 2021 - ncbi.nlm.nih.gov
Background Low-intensity extracorporeal shockwave therapy (LI-ESWT) may be a
successful complementary treatment approach for erectile dysfunction (ED). In this study, we …
successful complementary treatment approach for erectile dysfunction (ED). In this study, we …
Intracavernosal onabotulinumtoxinA exerts a synergistic pro-erectile effect when combined with sildenafil in spontaneously hypertensive rats
F Giuliano, C Joussain, P Denys… - The journal of sexual …, 2022 - academic.oup.com
ABSTRACT Background Botulinum toxin A (BTX-A) has a variety of uses in medicine. Some
evidence suggests that intracavernosal (ic) BTX-A injection administered in addition to …
evidence suggests that intracavernosal (ic) BTX-A injection administered in addition to …
[HTML][HTML] Low-intensity shock wave therapy for the treatment of vasculogenic erectile dysfunction: a narrative review of technical considerations and treatment outcomes
PS de Oliveira, MJ Ziegelmann - Translational Andrology and …, 2021 - ncbi.nlm.nih.gov
Erectile dysfunction (ED) impacts a significant portion of the aging male population.
Standard treatments such as oral medications, intracavernosal injections, intraurethral …
Standard treatments such as oral medications, intracavernosal injections, intraurethral …
A review of experimental techniques for erectile function researches and development of medical technology using animal erectile dysfunction models in sexual and …
T Kataoka, Y Hotta, K Kimura - Reproductive Medicine and …, 2023 - Wiley Online Library
Background Erectile dysfunction (ED) is one of the causes of male infertility and is a disease
that requires treatment. The first‐line drugs for ED are phosphodiesterase 5 (PDE‐5) …
that requires treatment. The first‐line drugs for ED are phosphodiesterase 5 (PDE‐5) …
Efficacy of penile low-intensity shockwave treatment for erectile dysfunction: correlation with the severity of cavernous artery disease
N Caretta, MDR Ponce, N Minicuci… - Asian Journal of …, 2021 - journals.lww.com
We analyzed the efficacy of penile low-intensity extracorporeal shockwave treatment for
erectile dysfunction (ED) combined with cavernous artery disease (CAD). ED was evaluated …
erectile dysfunction (ED) combined with cavernous artery disease (CAD). ED was evaluated …
Low-Intensity Shockwave Therapy (LI-ESWT) in diabetic kidney disease: results from an open-label interventional clinical trial
SM Skov-Jeppesen, KB Yderstraede… - … of Nephrology and …, 2021 - Taylor & Francis
Purpose Treatment with low-intensity shockwave therapy (LI-ESWT) is associated with
angiogenesis and is suggested as a treatment for different types of vascular diseases. It was …
angiogenesis and is suggested as a treatment for different types of vascular diseases. It was …